Previous 10 | Next 10 |
Awarded Extension to Existing Supply Tender which relates to Portfolio of Four Specialty IgG Products Acquired in 2021 Supply Extension Secures Ongoing Sales of Approximately $7.5 Million Per Year for 2023-2025, with an Option to Extend for up to Additional Two Years R...
Kamada Ltd. (KMDA) Q2 2022 Earnings Conference Call August 17, 2022 08:30 a.m. ET Company Representatives Amir London - Chief Executive Officer Chaime Orlev - Chief Financial Officer Bob Yedid - LifeSci Advisors Conference Call Participants Anthony Pe...
Kamada press release ( NASDAQ: KMDA ): Q2 GAAP EPS of -$0.09. Revenue of $23.6M (-2.5% Y/Y) misses by $0.09M . Fiscal Year 2022 GuidanceKamada continues to expect to generate fiscal year 2022 total revenues in the range of $125 million to $135 million vs consensus ...
Second Q uarter 202 2 R evenues were $2 3 . 6 M illion ; First Half 2022 Revenues of $51.7 Million Increased 5% Year-Over-Year First Half 2022 Adjusted EBITDA of $ 4.6 Million; Excluding Labor Strike Related Los...
Kamada ( NASDAQ: KMDA ) is scheduled to announce Q2 earnings results on Wednesday, August 17th, before market open. The consensus EPS Estimate is -$0.02 (-200.0% Y/Y) and the consensus Revenue Estimate is $23.69M (-2.1% Y/Y). Over the last 1 year, KMDA has beaten EPS...
Major earnings expected before the bell on Wednesday include: Lowe's Companies ( LOW ) Tencent Holdings ( OTCPK:TCEHY ) Target ( TGT ) The TJX Companies ( TJX ) ZIM Integrated Shipping Services ( ZIM ) For further details see: Notable earn...
REHOVOT, Israel and HOBOKEN, N.J., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a vertically integrated global biopharmaceutical company, focused on specialty plasma-derived therapeutics, today announced that it will release financial results for the second quart...
REHOVOT, Israel, July 15, 2022 (GLOBE NEWSWIRE) -- Kamada Ltd. (Nasdaq: KMDA) (KMDA.TA), a vertically integrated global biopharmaceutical company, focused on specialty plasma-derived therapeutics, announced today that the Company, the Employees’ Union of Kamada’s Beit Kama pro...
Procurement Agreement Following a N ew T ender Won from an I nternational Organization Operating Principally in Latin America Product Supply Expected During the Fourth Quarter of 2022 and the First Half of 2023 REHOVOT, I...
REHOVOT, Israel, and HOBOKEN, N.J., June 15, 2022 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), a vertically integrated global biopharmaceutical company, focused on specialty plasma-derived therapeutics, announced today the promotions of Shavit Beladev to Vice President respons...
News, Short Squeeze, Breakout and More Instantly...
2024-07-17 17:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-17 04:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...